AAV3B antibodies affect eligibility for liver-targeted gene therapy
A study found anti-AAV3B neutralizing antibodies in 33%–36% of healthy adults, with intermediate titers in 19% of positive individuals, while ...
Tag: liver-directed therapy
A study found anti-AAV3B neutralizing antibodies in 33%–36% of healthy adults, with intermediate titers in 19% of positive individuals, while ...